XML 62 R55.htm IDEA: XBRL DOCUMENT v3.25.1
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 24, 2023
Feb. 29, 2024
Mar. 31, 2023
Oct. 31, 2020
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Mar. 31, 2023
Mar. 31, 2024
Oct. 31, 2017
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Common stock, shares authorized         200,000,000   200,000,000     200,000,000  
Common stock, par value         $ 0.001   $ 0.001     $ 0.001  
Stock options to purchase, granted                 400,000    
Options shall vest 100,000         300,000          
Shares forfeited           25,000          
Expenses related to options         $ 33,568   $ 74,623      
Unrecognized compensation expense options             $ 98,040        
Weighted average remaining life (years)             1 year 9 months        
Unvested Stock Awards [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Weighted average remaining life (years)             2 years 5 months 26 days        
Unrecognized compensation expense other than options             $ 2,238,380        
Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants outstanding         1,721,256   1,721,256        
Issuance of warrants, description             Each warrant provides the holder the right to purchase up to one share of our Common Stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of Common Stock at an exercise price of $0.01 per share until December 2026; (2) warrants to purchase 911 shares of Common Stock at an exercise price of $1.65 per share until April 2025; (3) warrants to purchase 1,234,034 shares of our Common Stock at an exercise price of $2.00 per share consisting of 1% of the warrants that expired on August 2024, and 99% until February 2026; and (4) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025        
Warrant One [Member] | Until April 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock         911   911        
Warrants exercise price         $ 1.65   $ 1.65        
Warrant Two [Member] | Expired August 2024 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock         1,234,034   1,234,034        
Warrants exercise price         $ 2   $ 2        
Warrant Three [Member] | Until November 2025 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants issued to purchase common stock         386,311   386,311        
Warrants exercise price         $ 2.63   $ 2.63        
Common Stock [Member] | Equity Incentive Plan 2017 [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Number of common stock reserved and authorized                     485,000
Total shares available for issuance         2,704,900   2,704,900        
Total shares available under the plan   9,000,000                  
Additional common stock reserved and authorized   3,000,000 1,000,000 4,515,000